Login to Your Account

A Shire Thing?

Acceleron Files IPO For $75M; Celgene Promises to Buy More

By Randy Osborne
Staff Writer

Wednesday, August 7, 2013
Three months after Shire plc pulled the plug on their potential $498 million collaboration, Acceleron Pharma Inc. has filed for an initial public offering (IPO) that aims for about $74.7 million, and has extracted from its continuing partner Celgene Corp. a promise to buy more shares in an undisclosed amount at the IPO price, if the deal goes through.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription